This week from Drug Target Review...
EDITOR'S PICK
New hydrogel stem cell treatment could repair injured brain tissue
The new ‘hybrid’ hydrogel allowed researchers to safely deliver stem cells to the site of a brain injury in mice.
Researchers from the University of Melbourne, Australia and the Australian National University have developed new ‘hybrid’ hydrogel which was able to safely deliver stem cells to the site of a brain injury in mice... Read more>>>
===
TRENDING THIS WEEK
Transplanted brain organoids show response to visual stimuli in adult rats
Researchers say that by looking at individual neurons, they were able to gain a deeper understanding of the integration of transplanted brain organoids. Read more>>>
Weaponising SARS-CoV-2 spike protein against itself to prevent infection
By creating a drug that is based on part of the SARS-CoV-2 spike protein, US and Finnish researchers can block the virus from entering cells. Read more>>>
Researchers develop organoid models to study non-alcoholic fatty liver disease
The team used these models to show drug responses and established a CRISPR-screening platform to identify potential therapeutic targets for non-alcoholic fatty liver disease. Read more>>>
Scientists create organoid to understand hearing loss
The ground-breaking study is an important step towards modelling cochlear function in a dish. Read more>>>
===
WHAT TO LISTEN TO
Episode 17 – Imaging: data analysis of organoids
Tune into this podcast to hear experts discuss imaging and analysing data from organoids!
Part three of our Organoids Miniseries is now live! In this episode, sponsored by Molecular Devices, we discuss how to analyse complex data obtained from organoids.
This conversation features Dr Angeline Lim, a Senior Applications Scientist at Molecular Devices and Dr David Egan, Co-founder and CEO of Core Life Analytics.
===
WHAT TO WATCH
Discover our range of upcoming live webinars and on-demand sessions which are completely FREE to join.
===
JOIN THE COMMUNITY
Get your FREE subscription to Drug Target Review to stay up to date with the most pressing topics and trends in drug discovery and early-phase therapeutic development.
Cut down on screen time by listening to our podcasts, get intimate during our webinars or sip a cup of coffee whilst flicking through our journal. As a member, you’ll also gain exclusive access to:
- Breaking news and features
- Invitations to member only events
- Unlimited archive of whitepapers, ebooks, past issues and much more…
We provide compelling content contributed by the world's most respected scientists, key opinion leaders and influencers.
Want to keep up to date with our latest content? Follow us on LinkedIn, Facebook, Twitter and YouTube.
